Neuronal nitric oxide synthase (nNOS) has been suggested to be involve
d in cardiovascular homeostasis. We studied the regulation of nNOS exp
ression, determining nNOS mRNA expression levels in various tissues in
spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY). We
also investigated the effects of antihypertensive treatment with the
angiotensin II antagonist hydralazine or reserpine on nNOS mRNA expres
sion. The expression levels of nNOS mRNA and nNOS protein were determi
ned by Northern and Western blot analysis, respectively. NADPH-diaphor
ase histochemistry was used to identify cells in the adrenal medulla t
hat expressed nNOS. No significant differences in expression levels in
SHR and WKY were observed in the cerebellum and brain stem. nNOS mRNA
expression levels in the decapsular portion of the adrenal gland were
developmentally modulated and in a 24-week-old WKY were 2.5 times hig
her than in an age-matched SHR. This reduced expression of nNOS mRNA i
n the decapsular portion of the adrenal gland of SHR seemed to be resu
lt of hypertension in the SHR, because administration of either an ang
iotensin II antagonist (TCV-116) or hydralazine upregulated nNOS mRNA
expression in both SHR and WKY. Marked augmentation of nNOS mRNA expre
ssion in the decapsular portion of the adrenal gland by reserpine trea
tment suggested an intimate relation between nNOS in the decapsular po
rtion of the adrenal gland and the sympathoadrenal system. Reserpine t
reatment also increased the expression of nNOS protein; however, reser
pine treatment did not affect the distribution pattern of nNOS-positiv
e cells (NADPH-diaphorase-positive cells) in the adrenal medulla. The
present results suggest that nNOS gene expression in the decapsular po
rtion of the adrenal gland is not constitutive and that an intimate re
lation may exist between nNOS in the decapsular portion of the adrenal
gland and the sympathoadrenal system.